Providing Healthcare for Everyone Everywhere

Jointown Pharmaceutical Group Co., Ltd.

Strive to build up the most professional comprehensive health service platform in China

More
billion RMB
Operating Income in 2023
billion RMB
Net Income Attributable (Excl. Excep) in 2023
billion RMB
Net Cash Flow in 2023
billion RMB
Total Assets ending Sep. 30, 2024
people
Employees
th
Chinese Private Enterprise
th
Chinese Private Enterprise in Service Industry
Sino-Securities Index ESG Ratings
Digital Pharmaceutical Distribution and Supply Chain Business
General Agency Brand Promotion Business
Pharmaceutical Industrial Self-production and OEM Business
Pharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
Medical Health and Technology Value-added Services
Digital Logistics Technology and Supply Chain Solutions
Our Businesses

Digital Pharmaceutical Distribution and Supply Chain Business

More
Jointown is committed to providing upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
billion RMB
Sales Revenue in the first 3 quarters of 2024
billion RMB
Gross Profit in the first 3 quarters of 2024
+
Youngjoin Active Users
News Center

Company Dynamics And Industry Information

More
Corporate News
Improved operating performance quarter by quarter! Jointown's Q3 performance presentation held successfully
In the first three quarters of the year, Jointown's operating income, net profit attributable to the parent company, and net profit attributable to the parent company after deducting non-recurring profit and loss reached RMB 113.429 billion, RMB 1.696 billion and RMB 1.630 billion, respectively.
2024-11-01
More
Corporate News
Jointown Completed the Respond to Feedback on Jointown REIT, Stepping Closer to Listing
According to the disclosure of Shanghai Stock Exchange, on December 9, 2024, respond has been completed to the feedback on China Universal Jointown Pharmaceutical Warehousing and Logistics Closed-end REIT ("Jointown REIT"). This marks that Jointown REIT, as the first public REIT of the pharmaceutical logistics and warehousing facility in China, has taken one step closer to the final listing.
2024-12-10
More
Corporate News
Delegation from the Ministry of Health, the Kingdom of Saudi Arabia, Visited JOIN Digital Health Industry Park
On the afternoon of December 5, 2024, a delegation from the Ministry of Health, the Kingdom of Saudi Arabia (hereinafter referred to as Saudi delegation), visited JOIN Digital Health Industry Park (referred to as JDHIpark), and received warm reception from Mr. Liu Zhaonian, Jointown’s Vice Chairman, Mr. Lin Xinyang, the Shareholder Representative Supervisor, and Ms. Deng Huiyan, the General Manager of JDHIpark.
2024-12-06
More
Corporate News
Jointown was awarded the "2023 Golden Bull Award for Most Valuable Investment"
On 24 October, the 26th Golden Bull Award Ceremony for Listed Companies hosted by the China Securities Journal was held in Nantong, Jiangsu. Jointown Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jointown" or the "Company") was awarded the "2023 Golden Bull Award for Most Valuable Investment". Liu Zhifeng, Deputy General Manager and Board Secretary of Jointown, was invited to attend the ceremony and accepted the award on stage.
2024-10-24
More
Investor Relations

Stock Information

More
Jointown Pharmaceutical Group Co., Ltd. 600998.SH
5.39
-0.01 -0.19%
2024-12-20 16:22:29
Open 5.39
Previous Close 5.4
High 5.44
Low 5.36
Volume 22,026,257
Turnover 118,601,886RMB
Announcement
Q & A
ESG
Green development and technological empowerment create a sustainable future
Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
More

Jointown Service Platforms

Providing Healthcare for Everyone Everywhere

Jointown Pharmaceutical Group Co., Ltd.

Strive to build up the most professional comprehensive health service platform in China

billion RMB
Operating Income in 2023
billion RMB
Net Income Attributable (Excl. Excep) in 2023
billion RMB
Net Cash Flow in 2023
billion RMB
Total Assets ending Sep. 30, 2024
people
Employees
th
Chinese Private Enterprise
th
Chinese Private Enterprise in Service Industry
Sino-Securities Index ESG Ratings
More

Our Businesses

Digital Pharmaceutical Distribution and Supply Chain Business
Jointown is committed to providing upstream customers with full-channel and full-scenario digital distribution and promotion services, and downstream customers with "one-stop" full-variety digital supply chain services.
billion RMB
Sales Revenue in the first 3 quarters of 2024
billion RMB
Gross Profit in the first 3 quarters of 2024
+
Youngjoin Active Users
More
General Agency Brand Promotion Business
With its General Agency Brand Promotion (CSO) business moving into the fast lane, the Company continues to build the "second curve" for profit growth, and upgrades the brand of "ALL WAYS ENGINE".
billion RMB
Sales Revenue in the first 3 quarters of 2024
Product Specifications of Drugs
Product Specifications of Medical Devices
More
Pharmaceutical Industrial Self-production and OEM Business
Based on the existing varieties, brands, channels and marketing advantages, Jointown has conducted targeted development of self-operated industrial products and OEM business by virtue of big data accumulated by the Company's "hundred-billion-level" supply chain service platform. The business enjoys cluster development with respect to self-owned varieties.
billion RMB
Sales Revenue in the first 3 quarters of 2024
+
Varieties of Drug Production
OEM Product Specifications of Drugs
More
Pharmaceutical New Retail & Ten-Thousand Store Alliance Plan Business
New retail and Ten-Thousand Store Alliance Plan business is an integral part of Jointown's "Three News and Two Transformations" strategic transformation, and the core of new retail strategy. Jointown makes full use of the established supply chain advantages to empower the retailing business, reach C-end users and expand the business through the "Ten-Thousand Store Alliance Plan", "integration of wholesale and retail" and the combination of online and offline channels.
billion RMB
Sales Revenue in the first 3 quarters of 2024
Direct-Sale and Franchised Pharmacies
O2O Retail Stores
More
Medical Health and Technology Value-added Services
Jointown continues to carry out independent development and provides customers with information technology-driven value-added services; it also advances the development of medical diagnosis services, enhances public health service capabilities, and extends the business to medical services, health management, medical technology and other comprehensive health fields, to create a comprehensive health service platform.
million RMB
Sales Revenue in the first 3 quarters of 2024
Patent Rights of Technical Information
Software Copyright
More
Digital Logistics Technology and Supply Chain Solutions
Relying on Jointown Cloud Warehouse, Jointown expands the third-party/fourth-party business and cold chain business, providing technology output and supply chain solutions.
million RMB
Sales Revenue in the first 3 quarters of 2024
million m?
GSP Warehouse
Intelligent Logistics Patent
More

Company Dynamics And Industry Information

More
Corporate News
Improved operating performance quarter by quarter! Jointown's Q3 performance presentation held successfully
In the first three quarters of the year, Jointown's operating income, net profit attributable to the parent company, and net profit attributable to the parent company after deducting non-recurring profit and loss reached RMB 113.429 billion, RMB 1.696 billion and RMB 1.630 billion, respectively.
2024-11-01
Corporate News
Jointown Completed the Respond to Feedback on Jointown REIT, Stepping Closer to Listing
According to the disclosure of Shanghai Stock Exchange, on December 9, 2024, respond has been completed to the feedback on China Universal Jointown Pharmaceutical Warehousing and Logistics Closed-end REIT ("Jointown REIT"). This marks that Jointown REIT, as the first public REIT of the pharmaceutical logistics and warehousing facility in China, has taken one step closer to the final listing.
2024-12-10
Corporate News
Delegation from the Ministry of Health, the Kingdom of Saudi Arabia, Visited JOIN Digital Health Industry Park
On the afternoon of December 5, 2024, a delegation from the Ministry of Health, the Kingdom of Saudi Arabia (hereinafter referred to as Saudi delegation), visited JOIN Digital Health Industry Park (referred to as JDHIpark), and received warm reception from Mr. Liu Zhaonian, Jointown’s Vice Chairman, Mr. Lin Xinyang, the Shareholder Representative Supervisor, and Ms. Deng Huiyan, the General Manager of JDHIpark.
2024-12-06
Corporate News
Jointown was awarded the "2023 Golden Bull Award for Most Valuable Investment"
On 24 October, the 26th Golden Bull Award Ceremony for Listed Companies hosted by the China Securities Journal was held in Nantong, Jiangsu. Jointown Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Jointown" or the "Company") was awarded the "2023 Golden Bull Award for Most Valuable Investment". Liu Zhifeng, Deputy General Manager and Board Secretary of Jointown, was invited to attend the ceremony and accepted the award on stage.
2024-10-24

Stock Information

More
Jointown Pharmaceutical Group Co., Ltd.
600998.SH
5.39
Open 5.39
Previous Close 5.4
Volume 22,026,257
2024-12-20 16:22:29
-0.01 -0.19%
High 5.44
Low 5.36
Turnover 118,601,886RMB
Announcement
Q & A
Green development and technological empowerment create a sustainable future
Oriented by Green development and driven by innovation, we promote ESG practices through digitalization to create long-term value for the sustainable development of environment and society.
More

Jointown Service Platforms